E-LIB Suche - Ergebnisse für: Manegold, C.

1

Efficacy and safety of maintenance pemetrexed in patients w..:

Scagliotti, G.V. ; Gridelli, C. ; de Marinis, F....
Lung Cancer. 85 (2014) 3 - p. 408-414 , 2014

Link: https://doi.org/10.1016/..

2

Bone matters in lung cancer:

Brodowicz, T. ; O'Byrne, K. ; Manegold, C.
Annals of Oncology. 23 (2012) 9 - p. 2215-2222 , 2012

Link: https://doi.org/10.1093/..

3

VANTAGE 014: Vorinostat (V) in Patients With Advanced Malig..:

Krug, L.M. ; Kindler, H. ; Calvert, H....
European Journal of Cancer. 47 (2011) - p. 2-3 , 2011

Link: https://doi.org/10.1016/..

4

9096 POSTER EGFR-targeting Chimeric Monoclonal lgG-1 Antibo..:

Kortsik, C. ; Schmid-Bindert, G. ; Pilz, L.R....
European Journal of Cancer. 47 (2011) - p. S621 , 2011

Link: https://doi.org/10.1016/..

5

Molecular oncology in lung cancer – between biomarkers and ..:

Berger, W. ; Pircher, A. ; Sibilia, M....
memo - Magazine of European Medical Oncology. 4 (2011) 4 - p. 242-247 , 2011

Link: https://doi.org/10.1007/..

6

Functional imaging of lung cancer using dual energy CT: how..:

Schmid-Bindert, G. ; Henzler, Thomas ; Chu, T. Q....
European Radiology. 22 (2011) 1 - p. 93-103 , 2011

Link: https://doi.org/10.1007/..

7

Overall survival with cisplatin–gemcitabine and bevacizumab..:

Reck, M. ; von Pawel, J. ; Zatloukal, P....
Annals of Oncology. 21 (2010) 9 - p. 1804-1809 , 2010

Link: https://doi.org/10.1093/..

8

Clinical and biochemical features of aromatic L-amino acid ..:

Brun, L. ; Ngu, L.H. ; Keng, W.T....
Neurology. 75 (2010) 1 - p. 64-71 , 2010

Link: https://doi.org/10.1212/..

9

9144 Cetuximab in combination with gemcitabine/docetaxel or..:

Schumann, C. ; Pilz, L.R. ; Cicenas, S....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 548 , 2009

Link: https://doi.org/10.1016/..

10

Aromatic l‐amino acid decarboxylase deficiency: clinical fe..:

Manegold, C. ; Hoffmann, G. F. ; Degen, I....
Journal of Inherited Metabolic Disease. 32 (2009) 3 - p. 371-380 , 2009

Link: https://doi.org/10.1007/..

11

9172 Analysis of biomarkers (BMs) in the AVAiL phase III ra..:

Leighl, N. ; Reck, M. ; de Haas, S....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 558 , 2009

Link: https://doi.org/10.1016/..

12

Malignant peritoneal mesothelioma—Results from the Internat..:

Carteni, G. ; Manegold, C. ; Garcia, G. Martin...
Lung Cancer. 64 (2009) 2 - p. 211-218 , 2009

Link: https://doi.org/10.1016/..

13

9009 A meta-analysis of four randomized phase II/III trials..:

Pujol, J. ; Lynch, T.J. ; Rosell, R....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 508 , 2009

Link: https://doi.org/10.1016/..

14

151PD MULTIMODALITY THERAPY FOR MALIGNANT PLEURAL MESOTHELI..:

Bölükbas, S. ; Manegold, C. ; Fisseler-Eckhoff, A..
Lung Cancer. 64 (2009) - p. S63 , 2009

Link: https://doi.org/10.1016/..

15

9056 Evaluating the efficacy of zoledronic acid for the pre..:

Scagliotti, G. ; Manegold, C. ; de Marinis, F....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 522 , 2009

Link: https://doi.org/10.1016/..